Page last updated: 2024-08-24

cephalosporin c and cilastatin, imipenem drug combination

cephalosporin c has been researched along with cilastatin, imipenem drug combination in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (4.76)	18.7374
1990's	4 (19.05)	18.2507
2000's	6 (28.57)	29.6817
2010's	8 (38.10)	24.3611
2020's	2 (9.52)	2.80

Authors

Authors	Studies
Karrer, FM; Lilly, JR; Rothenberg, SS; Schroter, GP	1
Chimura, T	1
Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N	1
Nakagawa, Y; Toyoguchi, T	1
Akashi, K; Asayama, R; Gondo, H; Goto, T; Harada, N; Hayashi, S; Hisano, S; Ishikura, H; Kawasaki, C; Kozuru, M; Kumakawa, M; Morioka, E; Muta, K; Nakajima, H; Niho, Y; Nishimura, J; Okamura, T; Sawae, Y; Shibuya, T; Suehiro, Y; Suematsu, E; Uike, N; Yamasaki, K; Yamashita, S; Yufu, Y	1
Norrby, SR	1
Abe, T; Fukuoka, T; Inoue, H; Ohya, S	1
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P	1
Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P	1
Daimon, Y; Tanaka, K; Watanabe, K	1
Arnold, HM; Augustin, KM; Casabar, E; Dubberke, ER; Hladnik, LM; McKinnon, PS; Reichley, RM; Ritchie, DJ; Westervelt, P	1
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP	1
Akiyama, N; Fukushima, T; Hatanaka, K; Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Nakane, T; Ohyashiki, K; Takahashi, T; Tamaki, T; Tamura, K; Tanimoto, M; Tatsumi, Y; Urabe, A; Yoshida, I	1
Huttner, A	2
Ariyasu, M; Echols, R; Ferreira, JCA; Machida, M; Nagata, TD; Portsmouth, S; Tenke, P; van Veenhuyzen, D	1
Naber, KG; Wagenlehner, FME	1
Den Nagata, T; Echols, R; Portsmouth, S	1
Hsu, AJ; Tamma, PD	1
Garcia, JA; Liang, SY; Long, B; Matlock, A; Moussavi, K	1
Azanza Perea, JR; Sádaba Díaz de Rada, B	1

Reviews

5 review(s) available for cephalosporin c and cilastatin, imipenem drug combination

Article	Year
Clinical pharmacokinetics during continuous haemofiltration. Clinical pharmacokinetics, 1994, Volume: 26, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin	1994
Carbapenems in serious infections: a risk-benefit assessment. Drug safety, 2000, Volume: 22, Issue:3 Topics: Adult; Cephalosporins; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Tolerance; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Risk Assessment; Seizures; Thienamycins	2000
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections. Internal and emergency medicine, 2021, Volume: 16, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines	2021
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2 Topics: Adult; Albumins; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood Proteins; Catechols; Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Humans; Iron; Meropenem	2022

Trials

5 trial(s) available for cephalosporin c and cilastatin, imipenem drug combination

Article	Year
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Penicillins	1996
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome	2004
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Infection, 2007, Volume: 35, Issue:3 Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged	2007
Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins; Young Adult	2015
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Protease Inhibitors; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult	2018

Other Studies

11 other study(ies) available for cephalosporin c and cilastatin, imipenem drug combination

Article	Year
Cholangitis after the Kasai operation for biliary atresia. Journal of pediatric surgery, 1989, Volume: 24, Issue:8 Topics: Anti-Bacterial Agents; Biliary Atresia; Cephalosporins; Cholangitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Infant; Methylprednisolone; Portoenterostomy, Hepatic; Postoperative Care; Postoperative Complications; Prognosis	1989
[A clinical study on chemotherapies for chorioamnionitis]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:12 Topics: Amoxicillin; Ceftazidime; Cephalosporins; Chorioamnionitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Imipenem; Obstetric Labor, Premature; Pregnancy	1994
[Nephrotoxicity and drug interaction of vancomycin (2)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5 Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin	1996
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae]. The Japanese journal of antibiotics, 2001, Volume: 54, Issue:7 Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin	2001
[Epidemiological study on cigar-shaped clostridia isolated in a local Japanese general hospital]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:3 Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Clostridium; Clostridium Infections; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, General; Humans; Imipenem; Japan; Male; Penicillins	2008
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever. Pharmacotherapy, 2009, Volume: 29, Issue:8 Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Fever; Hospital Mortality; Humans; Imipenem; Male; Meropenem; Middle Aged; Neutropenia; Retreatment; Seizures; Thienamycins; Time Factors	2009
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units. Surgical infections, 2013, Volume: 14, Issue:1 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies	2013
Cefiderocol in context. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:12 Topics: Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Humans; Urinary Tract Infections	2018
Cefiderocol for treatment of complicated urinary tract infections. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:1 Topics: Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Humans; Urinary Tract Infections	2019
Cefiderocol for treatment of complicated urinary tract infections. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:1 Topics: Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Humans; Urinary Tract Infections	2019
Cefiderocol for treatment of complicated urinary tract infections - Author's reply. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:1 Topics: Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Humans; Urinary Tract Infections	2019